Oral Blood Glucose Regulators Market, Global Outlook and Forecast 2024-2030
The global Oral Blood Glucose Regulators market was valued at US$ 62970 million in 2023 and is projected to reach US$ 140390 million by 2030, at a CAGR of 12.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Biguanides Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Oral Blood Glucose Regulators include Bayer, Merck, Novartis, Huadong Medicine, Sanofi, Novo Nordisk, Servier, Takeda Pharmaceutical and Luye Pharmaceutical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Oral Blood Glucose Regulators are medications that are taken by mouth to manage blood sugar levels in people with type 2 diabetes.
This report aims to provide a comprehensive presentation of the global market for Oral Blood Glucose Regulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Blood Glucose Regulators. This report contains market size and forecasts of Oral Blood Glucose Regulators in global, including the following market information:
Global Oral Blood Glucose Regulators Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Oral Blood Glucose Regulators Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Oral Blood Glucose Regulators companies in 2023 (%)
We surveyed the Oral Blood Glucose Regulators manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Blood Glucose Regulators Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Oral Blood Glucose Regulators Market Segment Percentages, by Type, 2023 (%)
Biguanides
Sulfonylureas
Meglitinides
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
SGLT2 Inhibitors
Thiazolidinediones
Alpha-Glucosidase Inhibitors
Other
Global Oral Blood Glucose Regulators Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Oral Blood Glucose Regulators Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Other
Global Oral Blood Glucose Regulators Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Oral Blood Glucose Regulators Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Blood Glucose Regulators revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Oral Blood Glucose Regulators revenues share in global market, 2023 (%)
Key companies Oral Blood Glucose Regulators sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Oral Blood Glucose Regulators sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Merck
Novartis
Huadong Medicine
Sanofi
Novo Nordisk
Servier
Takeda Pharmaceutical
Luye Pharmaceutical
Taiji Group
CR Double-Crane
AstraZeneca
Boehringer Ingelheim
Qilu Pharmaceutical
Jiangsu Deyuan Pharmaceutical
CTTQ
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Blood Glucose Regulators, market overview.
Chapter 2: Global Oral Blood Glucose Regulators market size in revenue and volume.
Chapter 3: Detailed analysis of Oral Blood Glucose Regulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Blood Glucose Regulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oral Blood Glucose Regulators capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
